Form PRE 14C - Other preliminary information statements:
SEC Accession No. 0001144204-03-006019
Filing Date
2003-10-02
Accepted
2003-10-02 16:32:00
Documents
1
Period of Report
2003-10-02

Document Format Files

Seq Description Document Type Size
1 v00189.txt PRE 14C 15843
  Complete submission text file 0001144204-03-006019.txt   17451
Mailing Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 300 NEW YORK NY 10170 212-297-6221
HEMOXYMED INC (Filer) CIK: 0000872947 (see all company filings)

EIN.: 391661164 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14C | Act: 34 | File No.: 001-13835 | Film No.: 03924748
SIC: 2836 Biological Products, (No Diagnostic Substances)